Literature DB >> 25965958

Highly Stereoselective Synthesis of Lamivudine (3TC) and Emtricitabine (FTC) by a Novel N-Glycosidation Procedure.

Maria Federica Caso1, Daniele D'Alonzo1, Stefano D'Errico2, Giovanni Palumbo1, Annalisa Guaragna1.   

Abstract

The combined use of silanes (Et3SiH or PMHS) and I2 as novel N-glycosidation reagents for the synthesis of bioactive oxathiolane nucleosides 3TC and FTC is reported. Both systems (working as anhydrous HI sources) were devised to act as substrate activators and N-glycosidation promoters. Excellent results in terms of chemical efficiency and stereoselectivity of the reactions were obtained; surprisingly, the nature of the protective group at the N4 position of (fluoro)cytosine additionally influenced the stereochemical reaction outcome.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25965958     DOI: 10.1021/acs.orglett.5b00982

Source DB:  PubMed          Journal:  Org Lett        ISSN: 1523-7052            Impact factor:   6.005


  3 in total

1.  Synthesis of cyclic N (1)-pentylinosine phosphate, a new structurally reduced cADPR analogue with calcium-mobilizing activity on PC12 cells.

Authors:  Ahmed Mahal; Stefano D'Errico; Nicola Borbone; Brunella Pinto; Agnese Secondo; Valeria Costantino; Valentina Tedeschi; Giorgia Oliviero; Vincenzo Piccialli; Gennaro Piccialli
Journal:  Beilstein J Org Chem       Date:  2015-12-22       Impact factor: 2.883

2.  Toward the Identification of Novel Antimicrobial Agents: One-Pot Synthesis of Lipophilic Conjugates of N-Alkyl d- and l-Iminosugars.

Authors:  Anna Esposito; Daniele D'Alonzo; Stefano D'Errico; Eliana De Gregorio; Annalisa Guaragna
Journal:  Mar Drugs       Date:  2020-11-19       Impact factor: 5.118

3.  Expeditious synthesis and preliminary antimicrobial activity of deflazacort and its precursors.

Authors:  Anna Esposito; Eliana De Gregorio; Maria De Fenza; Daniele D'Alonzo; Anil Satawani; Annalisa Guaragna
Journal:  RSC Adv       Date:  2019-07-10       Impact factor: 4.036

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.